Literature DB >> 33483523

SHANK2 mutations impair apoptosis, proliferation and neurite outgrowth during early neuronal differentiation in SH-SY5Y cells.

Christine Unsicker1, Flavia-Bianca Cristian1, Manja von Hahn1, Volker Eckstein2, Gudrun A Rappold1, Simone Berkel3.   

Abstract

SHANK2 mutations have been identified in individuals with neurodevelopmental disorders, including intellectual disability and autism spectrum disorders (ASD). Using CRISPR/Cas9 genome editing, we obtained SH-SY5Y cell lines with frameshift mutations on one or both SHANK2 alleles. We investigated the effects of the different SHANK2 mutations on cell morphology, cell proliferation and differentiation potential during early neuronal differentiation. All mutant cell lines showed impaired neuronal differentiation marker expression. Cells with bi-allelic SHANK2 mutations revealed diminished apoptosis and increased proliferation, as well as decreased neurite outgrowth during early neuronal differentiation. Bi-allelic SHANK2 mutations resulted in an increase in p-AKT levels, suggesting that SHANK2 mutations impair downstream signaling of tyrosine kinase receptors. Additionally, cells with bi-allelic SHANK2 mutations had lower amyloid precursor protein (APP) expression compared to controls, suggesting a molecular link between SHANK2 and APP. Together, we can show that frameshift mutations on one or both SHANK2 alleles lead to an alteration of neuronal differentiation in SH-SY5Y cells, characterized by changes in cell growth and pre- and postsynaptic protein expression. We also provide first evidence that downstream signaling of tyrosine kinase receptors and amyloid precursor protein expression are affected.

Entities:  

Year:  2021        PMID: 33483523     DOI: 10.1038/s41598-021-81241-4

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  54 in total

Review 1.  PDZ domains and the organization of supramolecular complexes.

Authors:  M Sheng; C Sala
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

2.  Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation.

Authors:  Simone Berkel; Christian R Marshall; Birgit Weiss; Jennifer Howe; Ralph Roeth; Ute Moog; Volker Endris; Wendy Roberts; Peter Szatmari; Dalila Pinto; Michael Bonin; Angelika Riess; Hartmut Engels; Rolf Sprengel; Stephen W Scherer; Gudrun A Rappold
Journal:  Nat Genet       Date:  2010-05-16       Impact factor: 38.330

3.  Disruption of glutamate receptors at Shank-postsynaptic platform in Alzheimer's disease.

Authors:  Yuesong Gong; Carol F Lippa; Jinghua Zhu; Qishan Lin; Andrea L Rosso
Journal:  Brain Res       Date:  2009-07-25       Impact factor: 3.252

4.  Deficiency of Shank2 causes mania-like behavior that responds to mood stabilizers.

Authors:  Andrea L Pappas; Alexandra L Bey; Xiaoming Wang; Mark Rossi; Yong Ho Kim; Haidun Yan; Fiona Porkka; Lara J Duffney; Samantha M Phillips; Xinyu Cao; Jin-Dong Ding; Ramona M Rodriguiz; Henry H Yin; Richard J Weinberg; Ru-Rong Ji; William C Wetsel; Yong-Hui Jiang
Journal:  JCI Insight       Date:  2017-10-19

5.  Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders.

Authors:  Claire S Leblond; Jutta Heinrich; Richard Delorme; Christian Proepper; Catalina Betancur; Guillaume Huguet; Marina Konyukh; Pauline Chaste; Elodie Ey; Maria Rastam; Henrik Anckarsäter; Gudrun Nygren; I Carina Gillberg; Jonas Melke; Roberto Toro; Beatrice Regnault; Fabien Fauchereau; Oriane Mercati; Nathalie Lemière; David Skuse; Martin Poot; Richard Holt; Anthony P Monaco; Irma Järvelä; Katri Kantojärvi; Raija Vanhala; Sarah Curran; David A Collier; Patrick Bolton; Andreas Chiocchetti; Sabine M Klauck; Fritz Poustka; Christine M Freitag; Regina Waltes; Marnie Kopp; Eftichia Duketis; Elena Bacchelli; Fiorella Minopoli; Liliana Ruta; Agatino Battaglia; Luigi Mazzone; Elena Maestrini; Ana F Sequeira; Barbara Oliveira; Astrid Vicente; Guiomar Oliveira; Dalila Pinto; Stephen W Scherer; Diana Zelenika; Marc Delepine; Mark Lathrop; Dominique Bonneau; Vincent Guinchat; Françoise Devillard; Brigitte Assouline; Marie-Christine Mouren; Marion Leboyer; Christopher Gillberg; Tobias M Boeckers; Thomas Bourgeron
Journal:  PLoS Genet       Date:  2012-02-09       Impact factor: 5.917

6.  Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: a gradient of severity in cognitive impairments.

Authors:  Claire S Leblond; Caroline Nava; Anne Polge; Julie Gauthier; Guillaume Huguet; Serge Lumbroso; Fabienne Giuliano; Coline Stordeur; Christel Depienne; Kevin Mouzat; Dalila Pinto; Jennifer Howe; Nathalie Lemière; Christelle M Durand; Jessica Guibert; Elodie Ey; Roberto Toro; Hugo Peyre; Alexandre Mathieu; Frédérique Amsellem; Maria Rastam; I Carina Gillberg; Gudrun A Rappold; Richard Holt; Anthony P Monaco; Elena Maestrini; Pilar Galan; Delphine Heron; Aurélia Jacquette; Alexandra Afenjar; Agnès Rastetter; Alexis Brice; Françoise Devillard; Brigitte Assouline; Fanny Laffargue; James Lespinasse; Jean Chiesa; François Rivier; Dominique Bonneau; Beatrice Regnault; Diana Zelenika; Marc Delepine; Mark Lathrop; Damien Sanlaville; Caroline Schluth-Bolard; Patrick Edery; Laurence Perrin; Anne Claude Tabet; Michael J Schmeisser; Tobias M Boeckers; Mary Coleman; Daisuke Sato; Peter Szatmari; Stephen W Scherer; Guy A Rouleau; Catalina Betancur; Marion Leboyer; Christopher Gillberg; Richard Delorme; Thomas Bourgeron
Journal:  PLoS Genet       Date:  2014-09-04       Impact factor: 5.917

7.  Identification and functional characterization of rare SHANK2 variants in schizophrenia.

Authors:  S Peykov; S Berkel; M Schoen; K Weiss; F Degenhardt; J Strohmaier; B Weiss; C Proepper; G Schratt; M M Nöthen; T M Boeckers; M Rietschel; G A Rappold
Journal:  Mol Psychiatry       Date:  2015-01-06       Impact factor: 15.992

8.  Genomic diagnosis for children with intellectual disability and/or developmental delay.

Authors:  Kevin M Bowling; Michelle L Thompson; Michelle D Amaral; Candice R Finnila; Susan M Hiatt; Krysta L Engel; J Nicholas Cochran; Kyle B Brothers; Kelly M East; David E Gray; Whitley V Kelley; Neil E Lamb; Edward J Lose; Carla A Rich; Shirley Simmons; Jana S Whittle; Benjamin T Weaver; Amy S Nesmith; Richard M Myers; Gregory S Barsh; E Martina Bebin; Gregory M Cooper
Journal:  Genome Med       Date:  2017-05-30       Impact factor: 11.117

9.  Whole-genome sequencing in multiplex families with psychoses reveals mutations in the SHANK2 and SMARCA1 genes segregating with illness.

Authors:  O R Homann; K Misura; E Lamas; R W Sandrock; P Nelson; S I McDonough; L E DeLisi
Journal:  Mol Psychiatry       Date:  2016-03-22       Impact factor: 15.992

10.  SFARI Gene 2.0: a community-driven knowledgebase for the autism spectrum disorders (ASDs).

Authors:  Dan E Arking; Daniel B Campbell; Heather C Mefford; Eric M Morrow; Lauren A Weiss; Brett S Abrahams; Idan Menashe; Tim Wadkins; Sharmila Banerjee-Basu; Alan Packer
Journal:  Mol Autism       Date:  2013-10-03       Impact factor: 7.509

View more
  5 in total

Review 1.  A perspective on molecular signalling dysfunction, its clinical relevance and therapeutics in autism spectrum disorder.

Authors:  Sushmitha S Purushotham; Neeharika M N Reddy; Michelle Ninochka D'Souza; Nilpawan Roy Choudhury; Anusa Ganguly; Niharika Gopalakrishna; Ravi Muddashetty; James P Clement
Journal:  Exp Brain Res       Date:  2022-09-05       Impact factor: 2.064

2.  Quantitative proteomics and in-cell cross-linking reveal cellular reorganisation during early neuronal differentiation of SH-SY5Y cells.

Authors:  Marie Barth; Alicia Toto Nienguesso; Anne Navarrete Santos; Carla Schmidt
Journal:  Commun Biol       Date:  2022-06-07

3.  SHANK2 Mutations Result in Dysregulation of the ERK1/2 Pathway in Human Induced Pluripotent Stem Cells-Derived Neurons and Shank2(-/-) Mice.

Authors:  Anne-Kathrin Lutz; Andrea Pérez Arévalo; Valentin Ioannidis; Nadine Stirmlinger; Maria Demestre; Richard Delorme; Thomas Bourgeron; Tobias M Boeckers
Journal:  Front Mol Neurosci       Date:  2021-11-26       Impact factor: 5.639

4.  Cortactin Modulates Lung Endothelial Apoptosis Induced by Cigarette Smoke.

Authors:  Mounica Bandela; Eleftheria Letsiou; Viswanathan Natarajan; Lorraine B Ware; Joe G N Garcia; Sunit Singla; Steven M Dudek
Journal:  Cells       Date:  2021-10-24       Impact factor: 7.666

5.  Gene Dosage- and Age-Dependent Differential Transcriptomic Changes in the Prefrontal Cortex of Shank2-Mutant Mice.

Authors:  Seungjoon Lee; Hyojin Kang; Hwajin Jung; Eunjoon Kim; Eunee Lee
Journal:  Front Mol Neurosci       Date:  2021-06-11       Impact factor: 5.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.